AUXILIUM PHARMACEUTICALS INC
DelistedCIK 1182129fmd_00WPKX1TMHB4ZTRDQ59BRS25N0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2014, 23 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|---|
| Cost of revenue | 29 | 37 | 50 | 56 | 78 | 112 |
| Research and development | 54 | 51 | 48 | 62 | 46 | 50 |
| Selling, general and administrative | 89 | 129 | 165 | 180 | 186 | 250 |
| Operating income | (48) | (54) | (51) | (33) | 85 | (68) |
| Interest expense | – | 0 | 0 | 0 | 0 | 29 |
| Interest and investment income | 2 | 0 | 0 | 1 | 1 | – |
| Other non-operating income (expense) | – | – | – | 1 | 1 | 0 |
| Income before taxes | – | – | – | (33) | 86 | (96) |
| Income tax expense | – | – | – | 0 | 0 | (78) |
| Net income from continuing operations | – | – | – | (33) | 86 | (18) |
| Net income | (46) | (53) | (51) | (33) | – | – |
| Net income to common shareholders | – | – | (51) | (33) | 86 | (18) |